NO942864L - Benzo-condensed 5-ring heterocycles, process for their preparation, their use as a drug, their use as a diagnostic, and drug containing these - Google Patents

Benzo-condensed 5-ring heterocycles, process for their preparation, their use as a drug, their use as a diagnostic, and drug containing these

Info

Publication number
NO942864L
NO942864L NO942864A NO942864A NO942864L NO 942864 L NO942864 L NO 942864L NO 942864 A NO942864 A NO 942864A NO 942864 A NO942864 A NO 942864A NO 942864 L NO942864 L NO 942864L
Authority
NO
Norway
Prior art keywords
drug
benzo
diagnostic
condensed
preparation
Prior art date
Application number
NO942864A
Other languages
Norwegian (no)
Other versions
NO942864D0 (en
NO301584B1 (en
Inventor
Hans-Jochen Lang
Andreas Weichert
Jan-Robert Schwark
Wolfgang Scholz
Udo Albus
Peter Crause
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4326005A external-priority patent/DE4326005A1/en
Priority claimed from DE19944414316 external-priority patent/DE4414316A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO942864D0 publication Critical patent/NO942864D0/no
Publication of NO942864L publication Critical patent/NO942864L/en
Publication of NO301584B1 publication Critical patent/NO301584B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
NO942864A 1993-08-03 1994-08-02 Benzo-condensed 5-ring heterocycles, their use in the manufacture of drugs and diagnostics, as well as drugs containing these NO301584B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4326005A DE4326005A1 (en) 1993-08-03 1993-08-03 Benzo-fused 5-membered ring heterocycles, processes for their preparation, their use as a medicament, their use as a diagnostic, and medicament containing them
DE19944414316 DE4414316A1 (en) 1994-04-25 1994-04-25 New benzo-fused heterocyclyl-carbonyl-guanidine derivs.

Publications (3)

Publication Number Publication Date
NO942864D0 NO942864D0 (en) 1994-08-02
NO942864L true NO942864L (en) 1995-02-06
NO301584B1 NO301584B1 (en) 1997-11-17

Family

ID=25928286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942864A NO301584B1 (en) 1993-08-03 1994-08-02 Benzo-condensed 5-ring heterocycles, their use in the manufacture of drugs and diagnostics, as well as drugs containing these

Country Status (11)

Country Link
EP (1) EP0639573A1 (en)
JP (1) JPH07145149A (en)
KR (2) KR950005817A (en)
CN (1) CN1118347A (en)
AU (1) AU682371B2 (en)
CA (1) CA2129301A1 (en)
FI (1) FI943579A (en)
HU (1) HU218790B (en)
IL (1) IL110503A (en)
NO (1) NO301584B1 (en)
NZ (1) NZ264130A (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121391A1 (en) * 1993-04-28 1994-10-29 Atsuyuki Kojima Indoloylguanidine derivatives
US6169107B1 (en) 1993-04-28 2001-01-02 Sumitomo Pharmaceutical Co., Ltd. Indoloylguanidine derivatives
AU683552B2 (en) * 1994-04-11 1997-11-13 Chugai Seiyaku Kabushiki Kaisha 4,6-DI-t-butyl-2,3-dihydrobenzothiophene derivative
DE4412334A1 (en) * 1994-04-11 1995-10-19 Hoechst Ag Substituted N-heteroaroylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
CA2160600A1 (en) * 1994-10-18 1996-04-19 Masahumi Kitano Indoloylguanidine derivatives
US5834466A (en) * 1994-12-22 1998-11-10 The Regents Of The University Of California Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
ATE183498T1 (en) * 1995-04-18 1999-09-15 Hoechst Ag SUBSTITUTED INDENOYLGUANIDINES WITH ANTIARRHYTHMIC AND CARDIOPROTECTIVE EFFECTS
DE19540995A1 (en) * 1995-11-03 1997-05-07 Hoechst Ag Substituted sulfonimidamides, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
DE19542306A1 (en) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (en) * 1995-12-14 1997-06-19 Hoechst Ag Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations
DE19548708A1 (en) * 1995-12-23 1997-06-26 Merck Patent Gmbh Cyclic sulfones
DE19548812A1 (en) * 1995-12-27 1997-07-03 Hoechst Ag Use of inhibitors of the cellular Na · + · / H · + · exchanger (NHE) for the manufacture of a medicament for respiratory stimulation
CA2195697A1 (en) * 1996-02-02 1997-08-03 Masahumi Kitano Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
EP0886524A2 (en) * 1996-03-01 1998-12-30 Chiron Corporation Delivery of therapeutic agents to the prostate
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
CA2260499A1 (en) * 1998-01-29 1999-07-29 Sumitomo Pharmaceuticals Company Limited Pharmaceutical compositions for the treatment of ischemic brain damage
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
EP1056729B1 (en) * 1998-02-27 2004-12-29 Pfizer Products Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
US7314888B1 (en) 1998-11-05 2008-01-01 Toyama Chemical Co., Ltd. Compounds and medicinal use thereof
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
CA2370607A1 (en) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
AU1733701A (en) * 1999-12-16 2001-06-25 Sumitomo Pharmaceuticals Company, Limited Substituted guanidine derivatives
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
WO2002051805A1 (en) 2000-12-27 2002-07-04 Bayer Aktiengesellschaft Indole derivatives as ligands of thyroid receptors
DE10163239A1 (en) * 2001-12-21 2003-07-10 Aventis Pharma Gmbh Substituted imidazolidines, process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
SG148857A1 (en) 2002-03-13 2009-01-29 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
FR2842525B1 (en) * 2002-07-16 2005-05-13 Aventis Pharma Sa 3-GUANIDINOCARBONYL-1-HETEROARYL-INDOLE DERIVATIVES, PROCESS FOR THE PREPARATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
FR2842526B1 (en) * 2002-07-16 2007-07-13 Aventis Pharma Sa PHARMACEUTICAL COMPOSITIONS COMPRISING A 3-GUANIDINOCARBONYL-1-HETEROARYL-INDOLE DERIVATIVE, PROCESS FOR THE PREPARATION AS MEDICAMENTS
US7141600B2 (en) 2003-04-15 2006-11-28 The Regents Of The University Of California Small molecule inhibition of a PDZ-domain interaction
FR2856062B1 (en) * 2003-06-12 2005-11-11 Aventis Pharma Sa 3-GUANIDINOCARBONYL-HETEROCYCLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
AU2005254782A1 (en) 2004-06-18 2005-12-29 Biolipox Ab Indoles useful in the treatment of inflammation
WO2006007542A1 (en) 2004-07-01 2006-01-19 The Regents Of The University Of California Small molecule inhibition of a pdz-domain interaction
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (en) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Thienopyridine for treating hepatitis C
EP1831192B1 (en) * 2004-12-27 2011-08-24 Korea Research Institute Of Chemical Technology Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
DE602005026867D1 (en) 2005-01-19 2011-04-21 Biolipox Ab INFLAMMATORY INDOL DERIVATIVES
KR100644385B1 (en) * 2005-02-25 2006-11-10 동양수기산업(주) Suction-type sludge collecting device
CN101243046A (en) 2005-08-08 2008-08-13 安斯泰来制药有限公司 Acylguanidine derivative or salt thereof
TW200804345A (en) 2005-08-30 2008-01-16 Novartis Ag Substituted benzimidazoles and methods of preparation
CN101321761A (en) 2005-12-09 2008-12-10 霍夫曼-拉罗奇有限公司 Tricyclic amide derivatives useful for treating obesity
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
CA2636007A1 (en) 2006-01-13 2007-07-26 Wyeth Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors
CN101384549B (en) 2006-02-20 2011-04-13 安斯泰来制药株式会社 Pyrrole derivative or salt thereof
JP5157892B2 (en) 2006-02-20 2013-03-06 アステラス製薬株式会社 Amide derivatives or salts thereof
CN110003079A (en) * 2006-12-26 2019-07-12 兰休斯医疗成像公司 For making the ligand of imaging cardiac innervation
AU2011210765A1 (en) 2010-01-28 2012-09-13 President And Fellows Of Harvard College Compositions and methods for enhancing proteasome activity
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
CN103635230B (en) 2011-05-12 2017-10-31 普罗蒂斯特斯治疗公司 Albumen homeostasis conditioning agent
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
WO2014047427A2 (en) 2012-09-21 2014-03-27 Vanderbilt University Substituted benzofuran, benzothiophene and indole mcl-1 inhibitors
WO2014116228A1 (en) 2013-01-25 2014-07-31 President And Fellows Of Harvard College Usp14 inhibitors for treating or preventing viral infections
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2922341C (en) 2013-08-28 2022-06-07 Vanderbilt University Substituted indole mcl-1 inhibitors
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds
CN106456602B (en) 2014-03-27 2020-11-24 范德比尔特大学 Substituted indole MCL-1 inhibitors
JP6578349B2 (en) 2014-08-11 2019-09-18 アンジオン バイオメディカ コーポレーション Cytochrome P450 inhibitors and uses thereof
CN105884675A (en) * 2014-09-24 2016-08-24 中国药科大学 N-substituted indole carboxylic acid derivative and its preparation method and medical use
US9949965B2 (en) 2014-10-17 2018-04-24 Vanderbilt University Tricyclic indole Mcl-1 inhibitors and uses thereof
WO2016089648A1 (en) 2014-12-01 2016-06-09 Vtv Therapeutics Llc Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
EP3240778A4 (en) 2014-12-31 2018-07-11 Angion Biomedica Corp. Methods and agents for treating disease
US11596639B2 (en) 2016-03-04 2023-03-07 Vanderbilt University Substituted indole Mcl-1 inhibitors
CN105968059B (en) * 2016-05-12 2018-11-13 广西师范大学 N- alkenyl benzotriazole nitrogen oxygen derivatives and its preparation method and application
CN105820132B (en) * 2016-05-12 2018-11-13 广西师范大学 N- aryl benzotriazole nitrogen oxygen derivatives and its synthetic method
CN111960985A (en) * 2018-08-08 2020-11-20 中国人民解放军总医院 Antitumor compounds
WO2021226261A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
CN113967210A (en) * 2020-07-24 2022-01-25 上海交通大学医学院附属瑞金医院 Application of compound interfering integrin beta 3/Src interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE3304019A1 (en) * 1983-02-07 1984-08-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 3-ACYLOXY-1-PHENYL-2-AMINOCARBONYLINDOL COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3929582A1 (en) * 1989-09-06 1991-03-07 Hoechst Ag BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT
DE4127026A1 (en) * 1991-08-16 1993-02-18 Boehringer Ingelheim Kg New 3-amino-6-chloro:pyrazine 2-carboxamide derivs. - useful as hypotensive, mucolytic, diuretic and antitumoural drugs

Also Published As

Publication number Publication date
CA2129301A1 (en) 1995-02-04
AU682371B2 (en) 1997-10-02
KR950005817A (en) 1995-03-20
NZ264130A (en) 1995-12-21
EP0639573A1 (en) 1995-02-22
AU6884494A (en) 1995-02-16
FI943579A (en) 1995-02-04
FI943579A0 (en) 1994-08-01
KR950005512A (en) 1995-03-20
NO942864D0 (en) 1994-08-02
JPH07145149A (en) 1995-06-06
IL110503A (en) 2000-06-29
HU9402271D0 (en) 1994-09-28
NO301584B1 (en) 1997-11-17
KR100343292B1 (en) 2002-12-26
CN1118347A (en) 1996-03-13
HUT70547A (en) 1995-10-30
IL110503A0 (en) 1994-10-21
HU218790B (en) 2000-12-28

Similar Documents

Publication Publication Date Title
NO942864L (en) Benzo-condensed 5-ring heterocycles, process for their preparation, their use as a drug, their use as a diagnostic, and drug containing these
NO923466D0 (en) Heterocyclic Compounds with 5 Sections, PROCEDURE PREPARATION, AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS
DK654589A (en) HETEROCYCLIC DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
NO304468B1 (en) 6-membered nitrogen-containing heteroaryl-oxazolidinones, their use and drug containing the compound
NO179911C (en) Optically active 5H-pyrrolo [3,4-bpyrazine derivative as well as pharmaceutical preparations containing the derivative
NO952493D0 (en) Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing the compounds
NO944700D0 (en) New Thienothiazine Derivatives, Process for their Preparation and Pharmaceutical Preparations Containing the Compounds
NO894270L (en) SYNERGISTIC SWEATER, AND PROCEDURE FOR THE PREPARATION OF SUCH A.
FI940378A (en) 5-membered heterocycles, process for their preparation and drugs containing these compounds
NO890926D0 (en) TRIAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THEIR USE AS A DESTRUCTIVE AGENT.
DK0609798T3 (en) 4-Benzoylisoxazole derivatives as well as their use as herbicides
NO980273D0 (en) Five-membered heterocycles with biphenylsulfonyl substitution process for their preparation, their use as a drug or diagnostic, and drug containing the compound
NO308287B1 (en) Substituted 4-phenyl-6-amino-nicotinic acid derivatives, drugs containing them and their use
FI890488A (en) VAEXTEXTRAKT INNEHAOLLANDE PHARMACEUTICAL PREPARATION SAMT FOERFARANDE FOER FRAMSTAELLNING DAERAV.
DK378988D0 (en) DOPAMINE-BETA-HYDROXYLASE INHIBITORS, PROCEDURE FOR PREPARING IT, AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS
NO902786L (en) SHRIMP TOOL AND PROCEDURE FOR USING THIS.
NO960364L (en) Basic-substituted benzolguanidines, process for their preparation, their use as a drug or diagnostic, and drug containing the compound
DK486789A (en) BENZOXAZOLINON DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK135988A (en) 2,5-DIHYDROPYROLES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES
NO985171L (en) Sulfonamide-substituted fused 5-ring compounds, their use as a medicament, and pharmaceutical preparations containing the compounds
DK553689A (en) PHENYLOXYPROPANOLAMINE DERIVATIVES, PROCEDURE FOR PREPARING SUCH COMPOUNDS, AND MEDICINAL CONTAINING THESE
NO954739D0 (en) Substituted benzoylguanidines, processes for their preparation, their use as a drug or diagnostic, and drugs containing these compounds
NO970140D0 (en) Technetium-sulfonamide complexes, their use, pharmaceuticals containing them, and process for the preparation of the complexes and agents
DK165978C (en) 1-AMINOETHYL-1H-IMIDAZOLD DERIVATIVES, PROCEDURES FOR PREPARING IT, AND ANTIMYCOTIC AGENTS CONTAINING THESE
DK115289D0 (en) TRICYCLIC AMINE DERIVATIVES, PROCEDURES FOR PREPARING THEM, AND PHARMACEUTICAL AGENTS CONTAINING THESE

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002